Ranbaxy's return to US to be a long drawn process: Centrum Broking
Ranjit Kapadia of Centrum Broking discusses about the import ban on Ranbaxy's Mohali factory by the US Food and Drug Administration. He says that Ranbaxy's return to the US market is going to be a lengthy process.
